HKEX: 1011
2026 Interim Report
Earlier from China Nt Pharma
- Connected transaction in relation to loan capitalisation involving subscription of shares under specific mandate
- Supplemental announcement retirement of auditor
- China NT Pharma: PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
- China NT Pharma: PROFIT WARNING SUPPLEMENTAL ANNOUNCEMENT